AI-Driven Advancements in Biomaterials Science: A Narrative Review

Abstract

INTRODUCTION Biomaterials have emerged as a key component of contemporary medicine, propelling advancements in drug delivery, implants, and regenerative medicine. But conventional trial-and-error methods of finding new materials are sometimes cumbersome, resource-intensive, and ill-equipped to meet the demands of individual patients. AI IN HEALTH CARE By facilitating intelligent data analysis, diagnosis, and individualized therapy, artificial intelligence (AI), in particular, machine learning, deep learning, and data mining, has become a disruptive force in the health care industry. Its incorporation into biomaterials research opens up new avenues for clinical translation and innovation. PREDICTIVE MODELING AI systems are able to analyze sizable and intricate biological and material information in order to forecast attributes like mechanical strength, toxicity, biocompatibility, and in vivo response. These predictive skills enhance preclinical research ethics while speeding up the identification of biomaterials. DESIGN AND DEVELOPMENT AI makes it possible to create and modify biomaterials that are suited to a certain illness or a patient’s unique circumstances. Targeted medication delivery systems, customized implants, and physiologically sensitive smart materials are a few examples of applications. Materials informatics and high-throughput screening drastically cut down on development time and expense. FUTURE PROSPECTS In spite of its potential, integrating AI into biomaterials presents difficulties, including the requirement for reliable data privacy frameworks, transparent algorithms, and standardized, high-quality datasets. To get over these obstacles, multidisciplinary cooperation between data scientists, physicians, materials experts, and regulators is crucial. CONCLUSION AI is changing the biomaterials industry by improving the accuracy and efficiency of material design, selection, and testing. AI will continue to play a key role in developing next-generation biomaterials for predictive and individualized health care with sustained improvements and cooperative efforts.